Дерматология
98 статей · 34 журналов
Журналы подкатегории (34)
- Advances in Cosmetic Surgery · Elsevier (57)
- JAAD International · Elsevier (41)
- American Journal of Clinical Dermatology · Springer Nature (0)
- Anais Brasileiros de Dermatologia · Elsevier (0)
- Annales de Dermatologie et de Vénéréologie · Elsevier (0)
- Archives of Dermatological Research · Springer Nature (0)
- Australasian Journal of Dermatology · Wiley (0)
- Clinics in Dermatology · Elsevier (0)
- Current Dermatology Reports · Springer Nature (0)
- Dermatologic Clinics · Elsevier (0)
- Dermatology and Therapy · Springer Nature (0)
- Experimental Dermatology · Wiley (0)
- International Journal of Dermatology · Wiley (0)
- International Wound Journal · Wiley (0)
- JAAD Case Reports · Elsevier (0)
- JAAD Reviews · Elsevier (0)
- JDDG - Journal of the German Society of Dermatology · Wiley (0)
- JEADV Clinical Practice · Wiley (0)
- JID Innovations · Elsevier (0)
- Journal of Cosmetic Dermatology · Wiley (0)
- Journal of Dermatological Science · Elsevier (0)
- Journal of Dermatology · Wiley (0)
- Journal of Investigative Dermatology · Elsevier (0)
- Journal of Investigative Dermatology Symposium Proceedings · Elsevier (0)
- Journal of the American Academy of Dermatology · Elsevier (0)
- Journal of the European Academy of Dermatology and Venereology · Wiley (0)
- Lasers in Medical Science · Springer Nature (0)
- Lasers in Surgery and Medicine · Wiley (0)
- Pediatric Dermatology · Wiley (0)
- Photodermatology Photoimmunology and Photomedicine · Wiley (0)
- Piel · Elsevier (0)
- Pigment Cell and Melanoma Research · Wiley (0)
- Skin Research and Technology · Wiley (0)
- Wound Repair and Regeneration · Wiley (0)
-
Intraosseous schwannoma of the rib with bone destruction: a case report
Publication date: Available online 22 June 2026 Source: International Journal of Lung Cancer Author(s): Hiroyasu Matsuoka, Hirochika Matsubara, Mio Ota, Hiroyuki Nakajima
-
Adjuvant alectinib versus platinum-based chemotherapy in patients from Asia with completely resected ALK- positive non-small cell lung cancer (NSCLC): an exploratory subgroup analysis of ALINA including pharmacokinetics and safety in Japanese patients
Publication date: Available online 5 August 2026 Source: International Journal of Lung Cancer Author(s): Makoto Nishio, Benjamin J. Solomon, Fabrice Barlesi, Rafal Dziadziuszko, Yi-Long Wu, Cheng-Ta Yang, Dae Ho Lee, Hidehito...
-
Real-world safety, dose reduction determinants, and effectiveness of first-line osimertinib in EGFR -mutated non-small-cell lung cancer: a single-center retrospective cohort study
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Yuya Murase, Kazuhiko Shibata, Keiichi Iwasa, Yasutaka Shiba, Junya Suzuki, Satoshi Tanaka, Akihito Bando, Yukari Nakagawa,...
-
Definitive diagnosis of pleural mesothelioma by pleural effusion cytology: the MesoCyto study
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Masaki Hashimoto, Toshiyuki Minami, Ryuichi Waseda, Masaru Takenaka, Keigo Uchimura, Ayuko Sato, Takashi Kijima, Toshihiko Sato,...
-
Real-world evidence of postoperative adjuvant chemotherapy in patients with stage IA–IIIA non-small cell lung cancer in Japan
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Akira Hamada, Shigeru Sugiyama, Mizue Ogi, Masakazu Fujiwara, Kenichiro Nishida, Hiroshi Kitagawa, Yuko Oya
-
First-line taxane-versus pemetrexed-based chemoimmunotherapy for TTF-1–negative nonsquamous non–small cell lung cancer: a propensity score–matched study
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Kohei Otsubo, Yoshimasa Shiraishi, Takayuki Shimose, Keita Miura, Daiki Murata, Taichi Miyawaki, Hidehito Horinouchi, Taishi...
-
Thromboembolic events in non-small cell lung cancer patients treated with vascular endothelial growth factor inhibitors: A preliminary retrospective single-center study
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Ryuta Yamamoto, Kazunori Tobino, Hiroya Kawasaki, Hibiki Kiyosue, Hinako Kohri, Mizuki Muranaka, Motoki Yuasa, Shota Sogabe,...
-
Long-term outcomes of neoadjuvant nivolumab plus chemotherapy in resectable NSCLC in Japanese patients: final 5-year follow-up analysis from CheckMate 816
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Tetsuya Mitsudomi, Yasuhiro Tsutani, Hiroyuki Suzuki, Hiroyuki Ito, Noriaki Sakakura, Masahiro Seike, Shunichi Sugawara, Lily...
-
First-line pembrolizumab in metastatic non-small cell lung cancer: A clinical text-mining analysis of effectiveness, costs, and trial eligibility
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Hanieh Abedian-Kalkhoran, Hedwig M. Blommestein, Henk-Jan Guchelaar, Egbert F. Smit, Henk Codrington, Loes E. Visser, Juliëtte Zwaveling
-
Real-world comparison of carboplatin–pemetrexed–bevacizumab versus chemo-immunotherapy in EGFR-mutated lung cancer
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Tadashi Nishimura, Hajime Fujimoto, Hitoshi Sumitani, Yoshihiko Taniguchi, Akihiro Tamiya, Yoshinobu Matsuda, Takumi Fujiwara,...
-
Ixazomib enhances the antitumor effect of brigatinib in TP53 -mutated EML4-ALK lung cancer cells
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Sachiko Arai, Azusa Tanimoto, Koji Fukuda, Shigeki Nanjo, Shigeki Sato, Hiroshi Kotani, Seiji Yano
-
A comparison of cisplatin plus S-1 versus mitomycin C, vindesine, and cisplatin in concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer: A target trial emulation study using a clinical trial database
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Masato Karayama, Toshio Shimokawa, Katsuyuki Hotta, Katsuhiko Naoki, Isamu Okamoto, Seiji Niho, Shunichi Sugawara, Yuichi Ozawa,...
-
Real-world clinical outcomes of immune checkpoint inhibitors beyond 2 Years in patients with non-small cell lung cancer: A multicenter retrospective study
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Tomoyuki Ogata, Hiroaki Satoh, Masaharu Inagaki, Kunihiko Miyazaki, Toshihiro Shiozawa, Takeshi Numata, Koichi Kurishima, Jun...
-
Tumor size assessment for prediction of osimertinib efficacy in EGFR -mutated non–small cell lung cancer
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Tomonobu Nagase, Eiji Iwama, Hiroaki Ogata, Yuki Ikematsu, Daisuke Shibahara, Kohei Otsubo, Yoshimasa Shiraishi, Taishi Harada,...
-
A multicenter, randomized phase III trial comparing osimertinib with durvalumab after concurrent chemoradiotherapy in patients with unresectable, locally advanced non–small cell lung cancer harboring EGFR mutations: JCOG2502 (ODYSSEIA)
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Kota Kawabata, Keita Miura, Yasushi Goto, Yoshimasa Shiraishi, Shogo Nomura, Noriko Mitome, Haruhiko Fukuda, Isamu Okamoto,...
-
Effect of prior chemotherapy on survival in patients from the randomized phase III J-ALEX study of alectinib versus crizotinib in ALK -positive non-small cell lung cancer
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Tetsuya Mitsudomi, Makoto Nishio, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Shinji Takeuchi, Ryohei Katayama, Hiroyuki Sakaguchi,...
-
Real-world profile and clinical impact of central nervous system adverse events in patients with ALK -positive NSCLC treated with first-line lorlatinib in Japan: The first interim analysis from the ROYAL study
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Yutaka Fujiwara, Motohiro Tamiya, Eisaku Miyauchi, Yoshitaka Kawa, Noriko Yanagitani, Yuki Takeyasu, Ai Murata, Ikuyo Kawabata,...
-
Safety and effectiveness of capmatinib in patients with unresectable advanced/recurrent non-small cell lung cancer with MET ex14 skipping alterations: a post-marketing surveillance in Japan
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Kazuaki Yamaguchi, Satoshi Nomura, Ayako Honda, Naoko Suenaga
-
Isoform-specific prognostic value of pleural effusion TGF-β 2 in patients with lung cancer
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Riki Okita, Yuka Mimura-Kimura, Yusuke Mimura, Hisayuki Osoreda, Eiji Ikeda, Keisuke Aoe
-
Utility and limitations of generative artificial intelligence in therapeutic decision-making for advanced lung cancer: a simulation study and questionnaire survey
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Shogo Nakamura, Masato Karayama, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Noriyuki Enomoto,...
-
Clinical outcomes in early-stage lung cancer with interstitial lung disease: a comparative analysis of stereotactic body radiotherapy and proton beam therapy
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Gyo Uchida, Masaki Nakamura, Kenji Makita, Hidenari Hirata, Yuichi Hiroshima, Satoshi Saito, Toshiya Rachi, Yuki Miura, Kana...
-
Long-term nationwide post-marketing surveillance cohort study of nivolumab in advanced non-small-cell lung cancer
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Kentaro Ito, Nobuyuki Yamamoto, Daichi Fujimoto, Hiroaki Akamatsu, Yuichi Ozawa, Takehito Shukuya, Hidetoshi Hayashi, Koji...
-
Pulmonary combined large-cell neuroendocrine carcinoma with adenocarcinoma and pleomorphic carcinoma components: A case report
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Kohei Soejima, Hidehito Matsuoka, Yukio Kashima
-
Clinical utility of comprehensive genomic profiling in detecting actionable EGFR exon 20 insertions undetected by companion diagnostics: a case report
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Hideaki Motomura, Hiroaki Ikushima, Mizuki Fukuchi, Yutaro Ueki, Yu Ito, Yu Mikami, Masanori Kawakami, Akihisa Mitani, Keita...
-
Autoimmune hemolytic anemia following ipilimumab plus nivolumab therapy in a patient with malignant pleural mesothelioma: A case report
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Tomoko Yagi, Kentaro Tanaka, Fujiaki Mawatari, Yuusuke Nagata, Toshiaki Matsuda, Shunsuke Misono, Masahiro Shinmura, Hiromasa Inoue
-
Possible spontaneous regression of lung adenocarcinoma characterized by dense tumor-infiltrating lymphocytes and mature tertiary lymphoid structures: A case report
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Riki Okita, Yukari Hisamoto, Masanori Okada, Hidetoshi Inokawa, Eiji Ikeda
-
Serious abdominal complications during amivantamab-containing therapy in two patients with EGFR-mutated non-small cell lung cancer: case series
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Naoki Fujimoto, Kohei Fujita, Hiroki Fukuda, Saiki Yoshimura, Shogo Toyama, Takanori Ito, Takuma Imakita, Issei Oi, Osamu Kanai,...
-
Multiple thymic carcinoids: A case report
Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Kohei Soejima, Hidehito Matsuoka, Yukio Kashima, Ai Kameyama, Ryosuke Yoshimura, Yoshikazu Kotani, Takeyuki Kushima, Yoshimasa Maniwa
-
Clinical outcomes and Guardant360 circulating tumor DNA profiling in ALK-positive non-small cell lung cancer treated with lorlatinib after alectinib
Publication date: Available online 24 October 2026 Source: International Journal of Lung Cancer Author(s): Yasushi Goto, Tadaaki Yamada, Akehiro Nishiyama, Naoko Aragane, Minehiko Inomata, Hiroki Nagai, Satoshi Takahashi, Kazuhito...
-
Associations of CBR3 and SLC22A16 Variants with Efficacy and Grade 4 Neutropenia in Relapsed Small-Cell Lung Cancer Treated with Amrubicin
Publication date: Available online 18 November 2026 Source: International Journal of Lung Cancer Author(s): Tomohiro Onuki, Satoshi Fukuda, Toshiyasu Ito, Sanae Shiraga, Fumitaka Hashiba, Tatsuya Tanaka, Masashi Fujikawa, Tatsuro...